HighVista Strategies’s CVS Health CVS Stock Holding History

HighVista Strategies’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,800	Closed	-$309K	–	143
2018 Q2	$309K	Buy	+4,800	New	+$316K	0.14%	113

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

HighVista Strategies's CVS Position: Q3 2018 in Review

HighVista Strategies sold out of CVS Health (CVS) in Q3 2018, closing a stake of 4,800 shares — an estimated $309K sold.

HighVista Strategies first reported a position in CVS in Q2 2018 and held it in 1 quarter. The position peaked at $309K in Q2 2018. 1,600 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

HighVista Strategies reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
HighVista Strategies sold 4,800 CVS Health shares in Q3 2018, an estimated $309K.
HighVista Strategies first reported a position in CVS Health in Q2 2018 and held it in 1 quarter.
HighVista Strategies's CVS Health position peaked at $309K in Q2 2018.
1,600 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on HighVista Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.